A group of prominent AIDS activists is urging the New York attorney general to investigate Gilead Sciences (GILD) for potential antitrust violations in connection with deals the drug maker struck with rivals that sought to sell generic versions of a best-selling HIV treatment. The activists are concerned Gilead may have reached agreements with the companies that…
Photo: Fersolieslava licensed under (CC BY-SA 3.0)